share_log

RYTM将于11月05日盘后发布财报,一图速览分析师最新预测

Earnings Preview: RYTM to Report Financial Results Post-market on November 05

Futu News ·  Oct 31 09:00

$Rhythm Pharmaceuticals (RYTM.US)$ is scheduled to release its financial results post-market on November 05 ET.

Earnings Preview

Analysts estimate $Rhythm Pharmaceuticals (RYTM.US)$ to post revenue of USD32.32M for 2024Q3, up 43.64% YOY;

EPS is estimated to be USD-0.81, Net Loss Widened 6.15% YoY.

The accounting standard used for the above data is US-GAAP.

nn_stock_outlook_74878460052738_2024Q3_1730782800_2_1730336443888_en

Note:

  1. US-listed companies have full discretion in choosing their accounting year-end date, without being subject to any mandatory requirements. Consequently, every financial reporting period can act as the annual report cutoff date for a company, rather than following a natural calendar year as the fiscal year.

  2. Typically, companies host conference call around the date of the financial report publication to discuss the most recent financial results and operational performance while engaging with investors, analysts, and media. Investors are free to attend either through offline meetings or online conference calls.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment